Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, August 17, 2022
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
[ Wed, Aug 17th 2022
] - WOPRAI
Tue, August 16, 2022
[ Tue, Aug 16th 2022
] - WOPRAI
Arvind Ramnani Maintained (BLND) at Hold with Increased Target to $3.2 on, Aug 16th, 2022
Arvind Ramnani of Piper Sandler, Maintained "Blend Labs, Inc." (BLND) at Hold with Increased Target from $2.5 to $3.2 on, Aug 16th, 2022.
Arvind has made no other calls on BLND in the last 4 months.
There are 5 other peers that have a rating on BLND. Out of the 5 peers that are also analyzing BLND, 3 agree with Arvind's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Josh Beck of "Keybanc" Downgraded from Buy to Hold and Held Target at $5 on, Thursday, July 7th, 2022
- Jason Weaver of "Compass Point" Initiated at Hold and Held Target at $4.2 on, Wednesday, May 25th, 2022
- Michael Turrin of "Wells Fargo" Maintained at Hold with Decreased Target to $3 on, Friday, May 13th, 2022
These are the ratings of the 2 analyists that currently disagree with Arvind
- Ryan Tomasello of "Keefe, Bruyette & Woods" Downgraded from Hold to Sell and Decreased Target to $2.75 on, Monday, July 25th, 2022
- Michael Ng of "Goldman Sachs" Maintained at Strong Buy with Decreased Target to $7 on, Tuesday, April 19th, 2022
